ArticleJournal for immunotherapy of cancer2023

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice.

Xinyue Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.